MEDP - メッドペ―ス・ホ―ルディングス (Medpace Holdings Inc.) メッドペ―ス・ホ―ルディングス

 MEDPのチャート


 MEDPの企業情報

symbol MEDP
会社名 Medpace Holdings Inc (メッドペ―ス・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   IT・通信(IT_Communications)
概要 事業概要 メッドペース・ホールディングス(Medpace Holdings Inc.)は臨床契約研究機関である。同社は臨床研究に基づく医薬品及び医療機器開発サービスを提供する。同社は医薬品、バイオ技術、および医療機器企業と協力して、臨床試験の開発・実施を行う。同社の麻薬開発サービスは、フルサービス第I-IV臨床開発サービスを主として、開発計画の設計、コーディネートされた中央検査室、プロジェクト管理、規制業務、臨床モニタリング、データ管理および分析、薬物動態検査の新薬申請の提出、および販売後のマーケティング臨床サポートを含む。また、バイオアナリティカルラボサービス、臨床ヒト薬理学、イメージングサービス、および臨床試験のための心電図読み取りのサポートを提供する。同社の事業は、主に北米、欧州、アジアに拠点を置く。   メッドペ―ス・ホ―ルディングスは米国の臨床試験受託企業。持株会社体制で、子会社を通じ臨床試験サ―ビスをバイオ医薬品企業や医療器具メ―カ―などの医療業界全体に提供する。主に心臓病、代謝性疾患、がん、内分泌系疾患、神経系疾患などに対する臨床試験をフェ―ズ1からフェ―ズ4まで実施する。本社はオハイオ州シンシナティ。   Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
本社所在地 5375 Medpace Way Cincinnati OH 45227 USA
代表者氏名 August J. Troendle 8月J.Troendle
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 513-579-9911
設立年月日 41671
市場名 NASDAQ National Market System
ipoyear 2016年
従業員数 2500人
url www.medpace.com
nasdaq_url https://www.nasdaq.com/symbol/medp
adr_tso
EBITDA EBITDA(百万ドル) 118.75300
終値(lastsale) 57
時価総額(marketcap) 2027575728
時価総額 時価総額(百万ドル) 1865.725
売上高 売上高(百万ドル) 556.54600
企業価値(EV) 企業価値(EV)(百万ドル) 232.587
当期純利益 当期純利益(百万ドル) 49.25000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Medpace Holdings Inc revenues increased 57% to $333.2M. Net income applicable to common stockholders increased 72% to $31M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 22% to $14.8M (expense) Miscellaneous (expense) income net increase from $497K (expense) to $325K (income).

 MEDPのテクニカル分析


 MEDPのニュース

   TSLA Tumbles After S&P 500 Shun  2020/09/04 21:27:42 Zero Hedge
TSLA Tumbles After S&P 500 Shun Tyler Durden Fri, 09/04/2020 - 17:27 But, but, but… everyone was so certain!! S&P Dow Jones Indices have just issued a statement confirming new additions and deletions from their major indices. S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open of trading on Monday, September 21, 2020 to coincide with the September quarterly rebalance: S&P MidCap 400 constituents Etsy Inc. (NASD:ETSY), Teradyne Inc. (NASD:TER), and Catalent Inc. (NYSE:CTLT) will move to the S&P 500 , replacing H&R Block Inc. (NYSE:HRB) Coty Inc. (NYSE:COTY) and Kohl's Corp. (NYSE:KSS), all of which will move to the S&P MidCap 400. S&P SmallCap 600 constituents Wingstop Inc. (NASD:WING), Medpace Holdings Inc. (NASD:MEDP), and Fox Factory Holding Corp. (NASD:FOXF) will move to the S&P MidCap 400, replacing PBF Energy Inc. (NYSE:PBF), Allegheny Technologies Inc. (NYSE:ATI) and Mack-Cali Realty Corp. (NYSE:CLI), all of which will move to the S&P SmallCap 600.
   Medpace Holdings, Inc. to Report Third Quarter 2020 Financial Results on October 26, 2020  2020/09/02 20:05:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2020 financial results after the market close on Monday, October 26, 2020. The Company will host a conference call the following morning, Tuesday, October 27, 2020, at 9:00 a.m. ET to discuss these results. To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 6989449. To access the conference call v
   The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More  2020/07/29 11:32:01 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Medpace Holdings Inc (NASDAQ: MEDP ) (saw an extension of its earnings-induced momentum) NeoGenomics, Inc. (NASDAQ: NEO )(reacted to its second-quarter results) OncoSec Medical Inc (NASDAQ: ONCS ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Trevena Inc (NASDAQ: TRVN ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 28) Nkarta Inc (NASDAQ: NKTX ) Nurix Therapeutics Inc (NASDAQ: NRIX )(IPOed Friday) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN ) Stocks In Focus Alector Slips After Presenting Dementia Drug Trial Results Alector Inc (NASDAQ: ALEC ) announced at the virtual 2020 Alzheimer's Association International Conference, or AAIC, preliminary results from a Phase 1b and open-label Phase 2 studies of AL001 for the treatment of people with frontotemporal dementia with a progranulin gene mutation, or FTD-GRN, with the Phase 1 study showing AL001 was generally safe and well-tolerated.
   5 Stock Gainers on Tuesday: Kodak, Aurora Cannabis  2020/07/28 17:33:36 The Street
The stock market gainers Tuesday with shares rising are Kodak, Match Group, Medpace, Polaris and Aurora Cannabis.
   Medpace EPS beats by $0.28, beats on revenue (NASDAQ:MEDP)  2020/07/27 20:21:07 Seeking Alpha
Medpace (NASDAQ:MEDP): Q2 GAAP EPS of $0.64 beats by $0.28. Revenue of $205M (-4.3% Y/Y) beats by $23.83M. Press Release
   The Future of the Bioanalytical Testing Services Industry (2020-2025) Featuring Charles River, Medpace, Wuxi Apptec, Eurofins Scientific, IQVIA, SGS, and More - ResearchAndMarkets.com  2020/06/03 08:55:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Bioanalytical Testing Services Market by Type, Application, End User - Global Forecasts to 2025 " report has been added to ResearchAndMarkets.com's offering. The global bioanalytical testing services market is projected to reach USD 3.72 billion by 2025 from an estimated USD 2.13 billion in 2020, at a CAGR of 11.8% during the forecast period. This report analyzes the bioanalytical testing services market and aims at estimating the market size and future growth pote
   Medpace (MEDP) Q1 Earnings Miss Estimates  2020/04/28 23:05:05 Zacks Investment Research
Medpace (MEDP) delivered earnings and revenue surprises of -1.30% and 1.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Medpace : Q1 2020 Earnings Presentation | MarketScreener  2020/04/28 20:38:10 MarketScreener
Q1 2020 FINANCIAL RESULTS APRIL 28, 2020 F O RWA R D L O O K I N G S TAT E M E N T S & … | April 28, 2020
   Medpace Holdings, Inc. Reports First Quarter 2020 Results  2020/04/28 20:15:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2020. First Quarter 2020 Financial Results Revenue for the three months ended March 31, 2020 increased 15.0% to $230.9 million, compared to $200.7 million for the comparable prior-year period. On a constant currency organic basis, revenue for the first quarter of 2020 increased 15.2% compared to the first quarter of 2019. Backlog as of March 31,
   Medpace Holdings, Inc. to Report First Quarter 2020 Financial Results on April 28, 2020  2020/04/03 20:05:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will report its first quarter 2020 financial results after the market close on Tuesday, April 28, 2020. The Company will host a conference call the following morning, Wednesday, April 29, 2020, at 9:00 a.m. ET to discuss these results. To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 5203559. To access the conference call via
   The Future of the Bioanalytical Testing Services Industry (2020-2025) Featuring Charles River, Medpace, Wuxi Apptec, Eurofins Scientific, IQVIA, SGS, and More - ResearchAndMarkets.com  2020/06/03 08:55:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Bioanalytical Testing Services Market by Type, Application, End User - Global Forecasts to 2025 " report has been added to ResearchAndMarkets.com's offering. The global bioanalytical testing services market is projected to reach USD 3.72 billion by 2025 from an estimated USD 2.13 billion in 2020, at a CAGR of 11.8% during the forecast period. This report analyzes the bioanalytical testing services market and aims at estimating the market size and future growth pote
   Medpace (MEDP) Q1 Earnings Miss Estimates  2020/04/28 23:05:05 Zacks Investment Research
Medpace (MEDP) delivered earnings and revenue surprises of -1.30% and 1.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Medpace : Q1 2020 Earnings Presentation | MarketScreener  2020/04/28 20:38:10 MarketScreener
Q1 2020 FINANCIAL RESULTS APRIL 28, 2020 F O RWA R D L O O K I N G S TAT E M E N T S & … | April 28, 2020
   Medpace Holdings, Inc. Reports First Quarter 2020 Results  2020/04/28 20:15:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2020. First Quarter 2020 Financial Results Revenue for the three months ended March 31, 2020 increased 15.0% to $230.9 million, compared to $200.7 million for the comparable prior-year period. On a constant currency organic basis, revenue for the first quarter of 2020 increased 15.2% compared to the first quarter of 2019. Backlog as of March 31,
   Medpace Holdings, Inc. to Report First Quarter 2020 Financial Results on April 28, 2020  2020/04/03 20:05:00 Business Wire
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will report its first quarter 2020 financial results after the market close on Tuesday, April 28, 2020. The Company will host a conference call the following morning, Wednesday, April 29, 2020, at 9:00 a.m. ET to discuss these results. To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 5203559. To access the conference call via

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 メッドペ―ス・ホ―ルディングス MEDP Medpace Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)